Actinium Pharmaceuticals ATNM
NYSE ATNM
$1.14 -0.04 (-3.39%)
As of: Sep 29, 2026 · 3:59 PM EDT

Actinium Pharmaceuticals (ATNM) Receivables (2011)

Updated

Actinium Pharmaceuticals (ATNM) posted Receivables of $475,668 for Q4 2011.

Analysis

Actinium Pharmaceuticals (ATNM) Receivables (2011) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 19.05 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 13.82 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.56 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 9.64 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 15.68 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 10.23 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 5.06 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 12.49 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.13 Bn
10 Actinium Pharmaceuticals 37.10 Mn 37.10 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2011 475,668.00
API Access

Actinium Pharmaceuticals Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=ATNM&period=max&api_key=YOUR_API_KEY